Physician profile
Beth Bergman
NPI 1891901781
$1,056.24
in general payments reported to CMS, 2019-2025
10 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $11.54 · 2022: $175 · 2023: $190 · 2024: $362 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $870.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $297.00 | 2021-2025 | |
| Novo Nordisk INC | $194.94 | 2022-2024 | Rybelsus, Ozempic |
| Astellas Pharma US INC | $121.14 | 2023-2025 | Veozah |
| Lilly USA, LLC | $102.22 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $94.62 | 2024-2025 | Shingrix |
| Pfizer INC. | $92.05 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $55.27 | 2024-2025 | Airsupra, Farxiga, Breztri |
| Exact Sciences Corporation | $47.46 | 2023-2025 | Cologuard Collection Kit |
| Amgen INC. | $36.70 | 2025 | Repatha |
| Merck Sharp & Dohme LLC | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Bergman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.